Skip to main content
European Commission logo
Enterprise Europe Network

Romanian startup seeks R&D partners for certification and novel usecase development of a Class IIb AI-based digital mental health device

Summary

Profile Type
  • Business request
POD Reference
BRRO20250617014
Term of Validity
23 June 2025 - 23 June 2026
Company's Country
  • Romania
Type of partnership
  • Commercial agreement
Targeted Countries
  • All countries
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
A Romanian startup developing an AI-powered digital therapeutic platform for psychosis detection and auditory hallucination management seeks international R&D partners to support certification as a Class IIb medical device and codevelop novel use cases in defense, trauma care, and space applications.
Full Description
GOBLIN AI SRL is a Romanian startup founded in 2023, focused on delivering intelligent digital health solutions targeting mental health challenges in extreme or isolated environments. Its flagship innovation, the GOBLIN platform, combines eye-tracking, large language models (LLMs), and Avatar Therapy principles to detect and manage auditory hallucinations and psychotic episodes in real-time.
The company now seeks international research and development partners for two main objectives:
1. To support GOBLIN’s path to CE certification as a Class IIb medical device under the EU Medical Device Regulation (MDR), focusing on risk classification, clinical evidence collection, usability testing, and documentation for regulatory
approval.
2. To co-develop new use cases for GOBLIN’s modular and AI-based architecture in critical environments such as:
- Military and defense applications (PTSD, isolation-induced psychosis)
- Space medicine (astronaut psychological support in long-duration missions)
- Maritime or polar missions (remote resilience interventions)
- Emergency trauma therapy (acute psychosis and hallucination mitigation)
- Digital biomarkers for neuropsychiatric diagnostics
The partners will collaborate with GOBLIN AI on use-case validation, clinical scenario testing, and will be invited to join
future Horizon Europe and ESA-aligned consortia.
Advantages and Innovations
- Combines multiple AI technologies: eye-tracking, LLMs, and digital avatars
- Addresses early detection and real-time mitigation of psychosis symptoms
- Designed for use in inaccessible or high-stress environments (space, defense, maritime)
- Modular system for remote updates and integration with biometric wearables
- Supports non-invasive, autonomous interventions outside traditional healthcare facilities
- Readiness to evolve into a Class IIb CE-certified digital therapeutic
Technical Specification or Expertise Sought
We are looking for partners with expertise in any of the following:
- Medical device certification under MDR, especially for Class IIb devices
- Digital mental health interventions, e.g., AVATAR Therapy, CBTp, EMDR
- Clinical trials and usability studies involving AI-based tools
- Human factors engineering, user interaction in neurodigital interfaces
- Space medicine, defense mental health, or trauma care innovation
- Regulatory science and digital biomarker validation
- Semantic AI or AI model alignment for patient safety in LLMs
The ideal partner should be able to co-develop validation protocols, contribute to technical documentation for CE/MDR, and explore integration with existing clinical or operational workflows.
Stage of Development
  • Lab tested
Sustainable Development Goals
  • Goal 3: Good Health and Well-being
  • Goal 9: Industry, Innovation and Infrastructure
  • Goal 16: Peace and Justice Strong Institutions
IPR status
  • IPR applied but not yet granted

Partner Sought

Expected Role of a Partner
- Identification and piloting of novel use cases
- Joint development of testbeds for resilience, psychotrauma, or remote behavioral health
- Potential participation in EU-funded research proposals
Type and Size of Partner
  • SME 50 - 249
  • University
  • R&D Institution
  • SME 11-49
  • SME <=10
Type of partnership
  • Commercial agreement

Dissemination

Technology keywords
  • 06001014 - Neurology, Brain Research
  • 01003022 - Smart Appliances
  • 01003003 - Artificial Intelligence (AI)
  • 06001005 - Diagnostics, Diagnosis
  • 01003018 - User Interfaces, Usability
Market keywords
  • 05003006 - Other therapeutic (including defibrillators)
  • 05001007 - Other diagnostic
  • 05006 - Anatomy, Pathology, Immunology, Physiology
  • 05005022 - Other clinical medicine
  • 05007007 - Other medical/health related (not elsewhere classified)
Targeted countries
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antarctica
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bonaire, Saint Eustatius and Saba
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cabo Verde
  • Cambodia
  • Cameroon
  • Canada
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Cook Islands
  • Costa Rica
  • Croatia
  • Cuba
  • Curacao
  • Cyprus
  • Czechia
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • Dominican Republic
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Eswatini
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and McDonald Islands
  • Honduras
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jersey
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • North Korea
  • North Macedonia
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestinian Territory
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Republic of the Congo
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthelemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and the South Sandwich Islands
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Sweden
  • Switzerland
  • Syria
  • Taiwan
  • Tajikistan
  • Tanzania
  • Thailand
  • Timor Leste
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • U.S. Virgin Islands
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican
  • Venezuela
  • Vietnam
  • Wallis and Futuna
  • Western Sahara
  • Yemen
  • Zambia
  • Zimbabwe